Explore more Norwegian companies →
COMPANY CARD COMPANY
KRAGERØ TABLETTPRODUKSJON AS
Manufacture of pharmaceutical preparations
44,4 % EBIT margin
FINANCIALS
Financial statements and key figures
Company financial statements
Amount in NOK
| Financial statement item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Currency | NOK | NOK | NOK | NOK | NOK |
| Operating revenue | 31 126 343 | 33 067 792 | 28 634 605 | 21,587,000 | 20,046,000 |
| Operating profit | 13 813 041 | 15 073 124 | 16 014 510 | 12,273,000 | 9,812,000 |
| Net income | 11 449 036 | 12 668 693 | 12 918 240 | 9,688,000 | 7,723,000 |
| Equity | 31 435 499 | 28 576 907 | 32 662 216 | 20,935,000 | 12,365,000 |
| Total assets | 40 902 379 | 38 737 184 | 41 543 932 | 28,401,000 | 19,049,000 |
| Total liabilities | 9 466 879 | 10 160 277 | 8 881 717 | 7,466,000 | 6,684,000 |
| EBIT margin | 44,4 % | 45,6 % | 55,9 % | 56,9 % | 48,9 % |
Historical company accounts in NOK. The source identifies the year. A dash indicates an unavailable amount.
Indicators: equity / assets and EBIT / operating revenue. Midline is 0%, scale −100% to +100%. Not a credit assessment.
Show trend in NOK
Click the year markers for exact amounts. Missing years create gaps. The financial statement table above shows all amounts.
Click the year markers for exact amounts. Missing years create gaps. The financial statement table above shows all amounts.
Sources and conversion basis
Companies and corporate groups are kept separate. The same historical annual exchange rate is used for income statement and balance sheet figures. Missing values are shown as “—”. Actual zero values are retained.
- 2025 · NOK · original-NOK · source version 84d00c4034c9
- 2024 · NOK · original-NOK · source version 285965e14c5c
- 2023 · NOK · original-NOK · source version 8f8ae3c5c6be
Expand for more financial statement items. We show items with information in at least one year. “—” means a value is missing for that year.
Income statement12 entries with information
| Financial statement item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating revenue | |||||
| Total sales revenue | 31 126 343 | 33 052 792 | 28 634 605 | 21,587,000 | 20,046,000 |
| Total operating revenue | 31 126 343 | 33 067 792 | 28 634 605 | 21,587,000 | 20,046,000 |
| Operating expenses | |||||
| Wage costs | 3 878 059 | 4 216 940 | 4 001 583 | 3,950,000 | 4,425,000 |
| Total operating expenses | 17 313 302 | 17 994 668 | 12 620 095 | — | — |
| Operating profit | |||||
| Operating income (EBIT) | 13 813 041 | 15 073 124 | 16 014 510 | 12,273,000 | 9,812,000 |
| Financial income | |||||
| Total finance income | 904 274 | 1 185 720 | 594 728 | 155,000 | 100,000 |
| Financial expenses | |||||
| Other interest expense | — | 0 | 5 065 | 1,000 | — |
| Total finance costs | 39 064 | 16 931 | 45 966 | 9,000 | 10,000 |
| Net finance result | 865 210 | 1 168 789 | 548 762 | — | — |
| Results and tax | |||||
| Income before tax | 14 678 251 | 16 241 913 | 16 563 272 | 12,420,000 | 9,901,000 |
| Tax expense on ordinary income | 3 229 215 | 3 573 220 | 3 645 032 | 2,732,000 | 2,178,000 |
| Net income | 11 449 036 | 12 668 693 | 12 918 240 | 9,688,000 | 7,723,000 |
Balance sheet14 entries with information
| Financial statement item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Financial fixed assets | |||||
| Total non-current assets | 6 323 626 | 3 113 850 | 7 970 034 | 3,418,000 | 549,000 |
| Current assets | |||||
| Total inventory | — | 4 723 057 | 6 062 116 | — | — |
| Total receivables | 3 881 868 | 4 583 891 | 7 602 393 | 3,777,000 | 3,369,000 |
| Total investments | 0 | 0 | 0 | — | — |
| Total cash and cash equivalents | 23 283 227 | 26 316 386 | 19 909 390 | 15,508,000 | 11,398,000 |
| Total current assets | 34 578 752 | 35 623 334 | 33 573 899 | 24,984,000 | 18,499,000 |
| Total assets | 40 902 379 | 38 737 184 | 41 543 932 | 28,401,000 | 19,049,000 |
| Equity | |||||
| Total paid-in equity | 102 500 | 102 500 | 102 500 | 103,000 | 103,000 |
| Total retained earnings | 31 332 999 | 28 474 407 | 32 559 716 | 20,833,000 | 12,262,000 |
| Total equity | 31 435 499 | 28 576 907 | 32 662 216 | 20,935,000 | 12,365,000 |
| Provisions and long-term liabilities | |||||
| Total long-term liabilities | — | 20 663 | 0 | — | — |
| Current liabilities | |||||
| Total current liabilities | 9 288 140 | 10 139 613 | 8 881 717 | 7,466,000 | 6,684,000 |
| Total liabilities | 9 466 879 | 10 160 277 | 8 881 717 | 7,466,000 | 6,684,000 |
| Total | |||||
| Total equity and liabilities | 40 902 379 | 38 737 184 | 41 543 932 | 28,401,000 | 19,049,000 |
Some amounts for 2021 and 2022 come from a financial statements archive and are rounded to the nearest NOK 1,000. The source does not specify reporting dates or whether these figures cover the company or a group.
Reported dividends
| Financial year | Dividends – Income statement | Dividends – Balance sheet | Accounting scope |
|---|---|---|---|
| 2025 | 8 000 000 NOK | — | Not stated |
| 2024 | 16 000 000 NOK | — | Not stated |
| 2023 | — | — | — |
| 2022 | — | — | — |
| 2021 | 16 000 000 NOK | — | Not stated |
| 2020 | 6 000 000 NOK | 6 000 000 NOK | Company financial statements |
Income statement and balance sheet are separate accounting fields and must not be added together. “—” means that no amount is available for the year. It does not mean the amount is zero.
Source: Brønnøysundregistrene
Executive salary
| Financial year | Reported CEO salary |
|---|---|
| 2025 | — |
| 2024 | — |
| 2023 | — |
| 2022 | — |
| 2021 | — |
| 2020 | 961 000 NOK |
“—” means that no amount is available for the year. It does not mean the amount is zero.
Source: Brønnøysundregistrene · Amount in NOK
REGISTRY INFORMATION
Company at a glance
- Industry
- 21.200 · Manufacture of pharmaceutical preparations Industry classification: Statistics Norway · CC BY 4.0
- Registered address
- Kirkegata 15, 3770 KRAGERØ
- Founded
- 21.08.2002
- Entity type
- Main entity
ADDRESS AND PROPERTY
Property information
Kirkegata 15, 3770 KRAGERØ
Companies at the same address
Available company cards
About the address match
Same registered street address, postal code, and municipality. This does not document ownership, tenancy, or who uses the building. The address match does not identify a specific unit or dwelling. Open information does not show titleholders, sale date, plot area, or a complete building overview.
REGISTERED ROLES
The people and companies behind it.
| Name | Role | Source date |
|---|---|---|
| ENORA ASView role record | Accountant | 14.11.2026 |
| Ragnar SalmenBorn 1959 | Chair of the board | 14.11.2026 |
| Ragnar SalmenBorn 1959 | General manager | 14.11.2026 |
| REVISJONSSELSKAPET ASView role record | Auditor | 14.11.2026 |
Source: Brønnøysund Register Centre. A registered role is not documentation of direct contact information.
YEAR-DATED OWNERSHIP
Reported shareholders.
As of 31 December 2025 · 1 of 1 available ownership entries
| Shareholder | Share / share class | Source date |
|---|---|---|
| PHARMORE ASView ownership entryView share entries → | 100,00 % · Ordinary shares | 31.12.2025 |
- PHARMORE ASOrdinary shares100,00 %
Fixed scale 0–100%. Shares are not normalized. Any unfilled portion is outside the displayed total.
Source: Skatteetaten. Ownership share is a share of the number of shares, not necessarily voting rights or control. Person names refer to separate source records. Similar names are not automatically the same person.
Previously reported ownership entries (2)
- 2024 · PHARMORE AS · 100,00 %
- 2023 · PHARMORE AS · 100,00 %
YEAR-DATED OWNERSHIP
Company share entries
The company’s own investments in other businesses. Shareholders who own the company are shown under Ownership.
Source and scope
Skatteetaten / Aksjonærregisteret. Every level uses the same source year and source set. Further links follow Norwegian business registration numbers; foreign identifiers are not linked automatically. Calculated share is the product of reported share count / total shares at each level, not voting rights, control, or today’s shareholder register. Partial source coverage is stated at the relevant level; unresolved calculation basis is shown without a percentage.
Up to 500 source records examined; the view may be limited. Missing matches do not prove that ownership is absent.
YEAR-DATED OWNERSHIP
Indirect ownership
Explore documented ownership paths through companies. Each path and share class is shown separately; shares are not added together.
Source and scope
Skatteetaten / Aksjonærregisteret. Every level uses the same source year and source set. Further links follow Norwegian business registration numbers; foreign identifiers are not linked automatically. Calculated share is the product of reported share count / total shares at each level, not voting rights, control, or today’s shareholder register. Partial source coverage is stated at the relevant level; unresolved calculation basis is shown without a percentage.
Up to four ownership levels, 32 company lookups, and 250 chains are examined within a short time budget. This is a limited selection, not a ranking of the largest 250. Cycles are stopped. Missing matches do not prove that ownership is absent.
CONNECTIONS
Explore the ownership structure.
Directly reported ownership entries are shown first. Open the map to explore further.
Direct ownership entries without an interactive map
As of 31 December 2025 · 1 of 1 available ownership entries
| Shareholder | Share / share class | Source date |
|---|---|---|
| PHARMORE ASView ownership entryView share entries → | 100,00 % · Ordinary shares | 31.12.2025 |
Source: Skatteetaten / Aksjonærregisteret. Year-dated share ownership is not necessarily today’s voting rights or corporate control.
Open interactive map for direct ownership entries
CONNECTIONS
Explore the ownership structure.
See owners and open further company levels, using the same year throughout the tree.
Click a company to open owners. Select i for details.